Three year funding approval
After two years of temporary contract extensions from Cancer Australia for the Australasian Lung Cancer Trials Group (ALTG) funding, Cancer Australia recently called for applications for the Cancer Australia Support for Cancer Clinical Trials Program 2018-2021 Grant Funding for Multisite Collaborative Cancer Clinical Trials Groups. The ALTG is delighted to announce that our application to the Support for Cancer Clinical Trials Program 2018-2021 has been successful. The funding opportunity is $1.5million across 3 years and will commence 1 July, 2018. This significant milestone allows the ALTG in collaboration with the NHMRC Clinical Trials Centre to build on the Cancer Australia initiative by implementing new strategies to foster interest in clinical trial participation, increase multidisciplinary membership and facilitate membership collaboration with the goal to increase enrolment of patients in ALTG’s trials.